Unión Europea -
islandés -
EMA (European Medicines Agency)
pifeltro
merck sharp & dohme b.v. - doravirine - hiv sýkingar - veirueyðandi lyf til almennrar notkunar - pifeltro is indicated, in combination with other antiretroviral medicinal products, for the treatment of adults, and adolescents aged 12 years and older weighing at least 35 kg infected with hiv 1 without past or present evidence of resistance to the nnrti class.
Islandia -
islandés -
LYFJASTOFNUN (Icelandic Medicines Agency)
celecoxib actavis hart hylki 200 mg
actavis group ptc ehf. - celecoxibum inn - hart hylki - 200 mg
Islandia -
islandés -
LYFJASTOFNUN (Icelandic Medicines Agency)
candpress tafla 16 mg
teva b.v.* - candesartanum cílexetíl - tafla - 16 mg
Islandia -
islandés -
LYFJASTOFNUN (Icelandic Medicines Agency)
candpress tafla 8 mg
teva b.v.* - candesartanum cílexetíl - tafla - 8 mg
Islandia -
islandés -
LYFJASTOFNUN (Icelandic Medicines Agency)
candpress comp tafla 16 mg/12,5 mg
teva b.v.* - candesartanum cílexetíl; hydrochlorothiazide - tafla - 16 mg/12,5 mg
Islandia -
islandés -
LYFJASTOFNUN (Icelandic Medicines Agency)
celebra hart hylki 100 mg
upjohn eesv - celecoxibum inn - hart hylki - 100 mg
Islandia -
islandés -
LYFJASTOFNUN (Icelandic Medicines Agency)
celebra hart hylki 200 mg
upjohn eesv - celecoxibum inn - hart hylki - 200 mg
Islandia -
islandés -
LYFJASTOFNUN (Icelandic Medicines Agency)
celecoxib actavis hart hylki 100 mg
actavis group ptc ehf. - celecoxibum inn - hart hylki - 100 mg
Islandia -
islandés -
LYFJASTOFNUN (Icelandic Medicines Agency)
celecoxib medical hart hylki 100 mg
medical ehf. - celecoxibum inn - hart hylki - 100 mg
Islandia -
islandés -
LYFJASTOFNUN (Icelandic Medicines Agency)
celecoxib medical hart hylki 200 mg
medical ehf. - celecoxibum inn - hart hylki - 200 mg